Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · IEX Real-Time Price · USD
4.390
-0.110 (-2.44%)
At close: Jul 19, 2024, 4:00 PM
4.380
-0.010 (-0.23%)
Pre-market: Jul 22, 2024, 7:27 AM EDT
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $3.68 million as of July 22, 2024. Its market cap has decreased by -19.97% in one year.
Market Cap
3.68M
Enterprise Value
7.98M
1-Year Change
-19.97%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $11.20M to $3.68M, a decrease of -67.13%. That is a compound annual growth rate of -11.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 2.40M | 9.09% |
Dec 29, 2023 | 2.20M | -60.00% |
Dec 30, 2022 | 5.50M | -83.68% |
Dec 31, 2021 | 33.70M | 5.64% |
Dec 31, 2020 | 31.90M | -65.85% |
Dec 31, 2019 | 93.40M | 199.36% |
Dec 31, 2018 | 31.20M | 72.38% |
Dec 29, 2017 | 18.10M | 60.18% |
Dec 30, 2016 | 11.30M | 0.89% |
Dec 31, 2015 | 11.20M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Regional Health Properties | 3.77M |
Bio-Path Holdings | 3.77M |
Venus Concept | 3.75M |
Enveric Biosciences | 3.74M |
Fresh2 Group | 3.70M |
Applied DNA Sciences | 3.63M |
Avinger | 3.58M |
Lipella Pharmaceuticals | 3.48M |